Supplemental material
Open access
2,650
Views
18
CrossRef citations to date
0
Altmetric
Original Articles
Efficacy of hyperthermic intraperitoneal chemotherapy in patients with epithelial ovarian cancer: a meta-analysis
Qiwen WuDepartment of Gynecologic Oncology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, China;
http://orcid.org/0000-0002-1808-0972View further author information
Qianqian WuDepartment of Gynecologic Oncology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, China;
http://orcid.org/0000-0002-4986-5078View further author information
Jianying XuDepartment of Gynecologic Oncology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, China;
http://orcid.org/0000-0002-4786-7643View further author information
Xiaodong ChengDepartment of Gynecologic Oncology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, China;
http://orcid.org/0000-0002-6073-7261View further author information
Xinyu WangDepartment of Gynecologic Oncology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, China;
http://orcid.org/0000-0002-3173-6390View further author information
Weiguo LuDepartment of Gynecologic Oncology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, China; ;Center for Uterine Cancer Diagnosis & Therapy Research of Zhejiang Province, Hangzhou, China
http://orcid.org/0000-0002-8570-7317View further author information
Xiao LiDepartment of Gynecologic Oncology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, China; Correspondence[email protected]
http://orcid.org/0000-0002-8666-2974View further author information
Pages 561-571
|
Received 31 Oct 2018, Accepted 23 Apr 2019, Published online: 28 May 2019
Related Research Data
Cancer of the ovary, fallopian tube, and peritoneum
Source:
Wiley-Blackwell
Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CRS) in ovarian cancer: A systematic review and meta-analysis.
Source:
Elsevier BV
Consolidation hyperthermic intraperitoneal chemotherapy for the treatment of advanced stage ovarian carcinoma: a 3 year experience.
Source:
Springer Science and Business Media LLC
Current status and future prospects of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) clinical trials in ovarian cancer
Source:
Informa UK Limited
The Role of Hyperthermic Intraperitoneal Intraoperative Chemotherapy in Ovarian Cancer
Source:
Springer Nature
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: A Systematic Review and Meta-analysis
Source:
Springer Nature
Hyperthermic Intraperitoneal Chemotherapy after Secondary Cytoreduction in Epithelial Ovarian Cancer: A Single-center Comparative Analysis
Source:
Springer Nature
Reduction of cellular cisplatin resistance by hyperthermia—a review
Source:
Informa UK Limited
Cancer of the ovary, fallopian tube, and peritoneum
Source:
Wiley-Blackwell
Efficacy of hyperthermic intraperitoneal chemotherapy in patients with epithelial ovarian cancer: a meta-analysis
Source:
Figshare
Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer
Source:
Elsevier BV
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer
Source:
American Society of Clinical Oncology (ASCO)
Evaluation of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin in the Era of Value-Based Medicine
Source:
Springer Nature
Effects of temperature on the interaction of cisplatin and carboplatin with cellular DNA
Source:
Elsevier BV
Prognostic and predictive value of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) score in surgery for recurrent ovarian cancer
Source:
Elsevier BV
Cancer of the ovary, fallopian tube, and peritoneum
Source:
Wiley-Blackwell
Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Source:
American Society of Clinical Oncology (ASCO)
The Role of Hyperthermic Intraperitoneal Chemotherapy Using Paclitaxel in Platinum-Sensitive Recurrent Epithelial Ovarian Cancer Patients with Microscopic Residual Disease after Cytoreduction
Source:
Springer Nature
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
Source:
New England Journal of Medicine (NEJM/MMS)
Efficacy of hyperthermic intraperitoneal chemotherapy in patients with epithelial ovarian cancer: a meta-analysis
Source:
Figshare
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Source:
Massachusetts Medical Society
Treatment of microscopic disease with hyperthermic intraoperative intraperitoneal chemotherapy after complete cytoreduction improves disease-free survival in patients with stage IIIC/IV ovarian cancer.
Source:
Springer Science and Business Media LLC
The role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer: A Review
Source:
Springer Nature
Surgery in Recurrent Ovarian Cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial
Source:
Springer Science and Business Media LLC
Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy—current perspectives
Source:
MultiMed Inc.
Anti-Cancer Therapeutic Approaches Based on Intracellular and Extracellular Heat Shock Proteins
Source:
Bentham Science Publishers Ltd.
Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin.
Source:
Springer Science and Business Media LLC
Summary of current therapeutic options for peritoneal metastases from colorectal cancer
Source:
Wiley
Cytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study
Source:
Springer Science and Business Media LLC
Sarcoid reaction: a rare occurrence associated to colon adenocarcinoma (case report and literature review)
Source:
AME Publishing Company
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in recurrent epithelial ovarian cancer with peritoneal metastases: a single centre experience
Source:
Springer Nature
Survival Benefit of Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer: A Multi-institutional Case Control Study
Source:
Springer Nature
Malignant peritoneal mesothelioma—Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent
Source:
Elsevier BV
Heterogeneity in patients and methods. A problem for hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in ovarian carcinoma
Source:
Elsevier BV
The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer.
Source:
Springer Science and Business Media LLC
Critical evaluation of secondary cytoreduction in recurrent ovarian cancer
Source:
Elsevier BV
Hyperthermia versus Oncothermia: Cellular Effects in Complementary Cancer Therapy
Source:
Hindawi Limited
A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer
Source:
Elsevier BV
Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in rats
Source:
Elsevier BV
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Source:
Massachusetts Medical Society
Results of Treatment of 385 Patients With Peritoneal Surface Spread of Appendiceal Malignancy
Source:
Springer Nature
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Source:
Massachusetts Medical Society
Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study
Source:
American Society of Clinical Oncology (ASCO)
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: a case-control study on survival in patients with two year follow-up.
Source:
Elsevier BV
Intraperitoneal chemotherapy in the management of malignant disease
Source:
Informa UK Limited
Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer
Source:
American Society of Clinical Oncology (ASCO)
Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis
Source:
Elsevier BV
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.